Fibromyalgia is the second most common condition affecting your bones and muscles. Yet it’s often misdiagnosed and misunderstood. Its classic symptoms are widespread muscle and joint pain and fatigue.
Doctors aren’t sure what causes it, but some believe it’s a problem with how your brain and spinal cord process pain signals from your nerves.
Certain things suggest you’re more likely to get it:
- You have another painful disease, such as arthritis, or an infection.
- You are a woman.
- Suffer from a disorder, like anxiety or depression.
- You were physically or emotionally abused or have PTSD.
Common symptoms include:
- Muscle pain, burning, twitching, or tightness
- Low pain threshold or tender points
- Trouble concentrating and remembering
- Feeling nervous, worried, or depressed
When a person sustains an injury or is in pain, Cannabinoids decrease the release of activators and sensitizers. This stabilizes the nerve call, thereby preventing excessive firing and in turn calms immune cells and preventing the release of substances that promote inflammation.
CBD is recognized for its pain-relieving (analgesic) and anti-inflammatory effects.
In an online survey of over 1,300 fibromyalgia patients conducted by the National Pain Foundation, 62% of those who had tried Cannabis said it was effective at treating their fibromyalgia. (2014)
- Cannabinoids for fibromyalgia
- Clinical endocannabinoid deficiency (CECD)
- Cannabis use in patients with fibromyalgia
- Association of Herbal Cannabis Use With Negative Psychosocial Parameters in Patients With Fibromyalgia
- Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions
- Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
- Marijuana Rated Most Effective for Treating Fibromyalgia
A migraine, fibromyalgia, IBS and related conditions display common patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines.